Photo courtesy of © ASCO/MedMeetingImages

St. Jude at ASCO 2019

Caring for Every Patient, Learning From Every Patient

 

At the 2019 annual meeting of the American Society of Clinical Oncology, investigators and clinicians from St. Jude Children’s Research Hospital present data on how chronic health conditions affect childhood cancer survivors. Novel therapies for solid tumors and the newly expanded resources in St. Jude Cloud are among the topics St. Jude experts will discuss at the five-day meeting that begins Friday, May 31, in Chicago.

Read the full press release

St. Jude CEO Presents Award Lecture

St. Jude President and CEO James R. Downing, MD

The Molecular Pathology of Pediatric Cancer
Sunday, June 2: 11:30 a.m.–12:15 p.m.
Location: S504

St. Jude President and CEO James R. Downing, MD, gives the 2019 Pediatric Oncology Award and Lecture on the molecular pathology of pediatric cancer. Downing was awarded the honor for his scientific achievements and leadership in the field of pediatric oncology.

Read the Press Release


 

St. Jude Cloud

St. Jude Cloud is a data-sharing resource for the global research community. More than 600 clinical genomic cases are now available in St. Jude Cloud. Researchers can explore unique next-generation sequencing data and analysis tools, including the newly launched GenomePaint, for pediatric cancer and other life-threatening diseases.

Learn more at Booth #3064

Read More About the Latest Developments


 

Select Oral Abstracts

When: Friday, May 31 from 3:57 – 4:09 p.m. CST
Where: S504
Title: Safety and activity of venetoclax in combination with high-dose cytarabine in children with relapsed or refractory acute myeloid leukemia.
Oral Abstract session: Pediatric Oncology I
Abstract 10004

Jeffrey Rubnitz, MD, PhD, of the Department of Oncology will discuss safety and activity of venetoclax in combination with high-dos cytarabine in children with relapsed or refractory acute myeloid leukemia.


 

When: Sunday, June 2 from 8:00 — 8:12 a.m.
Where: S504
Title: Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.
Oral Abstract session: Pediatric Oncology II
Abstract 10009

Giles Robinson, MD, of the Department of Oncology will discuss a Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system tumors.


 

When: Sunday, June 2 from 10:12 – 10:24 a.m.
Where: S504
Title: Chronic health conditions (CHC) and late mortality in survivors of acute lymphoblastic leukemia (ALL) in the Childhood Cancer Survivor Study.
Oral Abstract session: Pediatric Oncology II
Abstract 10016

Stephanie Dixon, MD, of the Department of Oncology will discuss chronic health conditions and late mortality in survivors of acute lympoblastic leukemia in the Childhood Cancer Survivor Study.

  1. Date: Saturday, June 1
    Time: 1:45 – 1:57 p.m.
    Location: S504
    Poster Discussion Session: Pediatric Oncology

    Alberto Pappo, MD, director of the Developmental Biology and Solid Tumor Program at St. Jude will discuss investigating pediatric solid tumors: from single institution to international collaboration. This poster session discussion will include information from the Malignant Germ Cell Tumor International Consortium (MaGIC) as well as preliminary results around emerging treatment options.


     

    Date: Monday, June 3
    Time: 4:30 – 4:42 p.m.
    Location: S102
    Poster Discussion Session: Symptoms and Survivorship

    Tara Brinkman, PhD, will discuss “Attention Gen AYA.” This poster session discussion will include information about how physical and mental health can affect young adult cancer patients and survivors.

  2. Pediatric Oncology Posters

    When: Saturday, June 1 at 8:00 – 11:00 a.m.
    Location:
    Hall A

    Abstract Author
    10019: Real-time sharing of comprehensive clinical genomics sequencing data in St. Jude Cloud.
    Poster #401
    Scott Newman, PhD
    10026: Frailty among childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
    Poster #408
    Samah Hayek, DrPh
    10027: Impact of protein supplementation on lean muscle mass in adult survivors of childhood cancer engaged in resistance training.
    Poster #409
    Matthew Krull
    10048: Renal function after treatment for childhood cancer: A report from the St. Jude Lifetime Cohort Study
    Poster #430
    Daniel Green, MD
    10049: Patient reported outcomes (PROs) in adult survivors of childhood hematopoietic cell transplant (HCT): A report from the St. Jude lifetime cohort study
    Poster #431
    Neel Bhatt, MBBS, MPH
    10052: Cost-effectiveness of screening guidelines to present heart failure in childhood cancer survivors: A report from the Childhood Cancer Survivor Study.
    Poster #434
    Matthew Ehrhardt, MD
    10057: Progression of frailty in young adult survivors of childhood cancer: St. Jude Lifetime Cohort
    Poster #439
    Kirsten Ness, PhD
    10058: Cardiac events in survivors of childhood cancer treated in more recent eras: A report from the Childhood Cancer Survivor Study
    Poster #440
    Daniel Mulrooney, MD, MS
    10060: Polygenic risk of subsequent thyroid cancer after childhood cancer: A report from the St. Jude Lifetime Cohort (SJLIFE) and childhood cancer survivor study (CCSS)
    Poster #442
    Zhaoming Wang, PhD

    Cancer Prevention, Hereditary Genetics, and Epidemiology Posters

    When: Monday, June 3 at 1:15 – 4:15 p.m.
    Location:
    Hall A

    Abstract Author
    1516: Genome-wide association study using whole-genome sequencing to identify a novel locus associated with cardiomyopathy risk in adult survivors of childhood cancer: Utility of a two-stage analytic approach.
    Poster #10
    Yadav Sapkota, PhD

St. Jude Pioneer Recognized in 2019 Giants of Cancer Care

Donald Pinkel, MD

First St. Jude CEO and Director Donald Pinkel, MD, revolutionized pediatric acute lymphoblastic leukemia treatment. This year, he is honored by OncLive as a 2019 inductee to the Giants of Cancer Care for his work in pediatric oncology.

Read the Research Highlight
Learn More About Dr. Pinkel's Career at St. Jude